OHSU

Dr. Gray elected to the Institute of Medicine Share This OHSU Content

Joe Gray, PhDJoe Gray, PhD, Professor and Chair, Department of Biomedical Engineering and Director, OHSU Center for Spatial Systems Biomedicine, has been elected to the Institute of Medicine (IOM). Three other OHSU faculty members are IOM members: Brian Druker, MD, elected in 2003; Richard Goodman, MD, PhD, elected in 2005; and Gary Westbrook, MD, elected in 2008. The IOM has a total active membership of 1,688. Bruce (Ned) Calonge, MD, MPH, R '84 was also elected.

Members of the IOM are called upon to provide advice to the government as it strives to improve the nation's health. They are elected by current active members through a highly selective process that recognizes individuals who have made major contributions to the medical sciences, health care and public health. A branch of the National Academy of Sciences, the Institute of Medicine has become recognized as a national resource for independent, scientifically informed analysis and recommendations on health issues.

Dr. Gray, also a lead scientist in the OHSU Knight Cancer Institute, joined OHSU in January 2011. He is known for, among other things, developing the FISH test that transformed how treatments are selected for breast cancer patients. He co-leads the Stand Up To Cancer initiative’s “Breast Cancer Dream Team,” serves as a key player in the Cancer Genome Atlas Project and is spearheading the use of computer models to predict how promising targeted therapies will work in attacking cancer cells. The new Collaborative Life Sciences Building will house “vibration-free” lab space for Dr. Gray and other scientists in the OHSU Center for Spatial Systems Biomedicine.

The IOM was established in 1970 as the health branch of the National Academy of Sciences, and is recognized as a national resource for independent, scientifically informed analysis and recommendations on health issues. The IOM announced the names of 65 new members and five foreign associates Oct. 17 in conjunction with its 41st annual meeting.

Particulars:

  • Dr. Druker is Director, OHSU Knight Cancer Institute and Associate Dean for Oncology 
  • Dr. Goodman is Director and Senior Scientist, Vollum Institute and Professor, Department of Cell and Developmental Biology
  • Dr. Westbrook is Co-Director and Senior Scientist, Vollum Institute and Professor, Department of Neurology